Literature DB >> 2827675

Regulation of lactate/pyruvate ratios by cyclic AMP in Neurospora crassa.

M L Pall1, C K Robertson.   

Abstract

Cyclic AMP is thought to have a general role in stimulating the breakdown of carbohydrate reserves and subsequent glycolytic activity. This would be expected to increase the availability of reducing equivalents in the form of cytoplasmic NADH. The current study examines another potential reaction controlling cytoplasmic NADH in the fungus Neurospora crassa, that of lactate dehydrogenase, to determine whether it is also regulated by cyclic AMP. The cr-1, adenylate cyclase and cyclic AMP-deficient mutant, grown with and without exogenous cyclic AMP was compared with an isogenic wild type. The results show that cyclic AMP raises pyruvic acid pools and lowers both lactic acid pools and lactate/pyruvate ratios. It does that, in part or in whole, by lowering lactate dehydrogenase activity. The possibility that cytoplasmic NAD+/NADH is a major target of cyclic AMP control is discussed. The high performance liquid chromatography procedures used in these studies are applicable to the measurement of intracellular pools of tricarboxylic acid cycle and other organic acids.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2827675     DOI: 10.1016/0006-291x(88)90529-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Use of 1H nuclear magnetic resonance to measure intracellular metabolite levels during growth and asexual sporulation in Neurospora crassa.

Authors:  James D Kim; Kayla Kaiser; Cynthia K Larive; Katherine A Borkovich
Journal:  Eukaryot Cell       Date:  2011-04-01

2.  Structures of Saccharomyces cerevisiae D-arabinose dehydrogenase Ara1 and its complex with NADPH: implications for cofactor-assisted substrate recognition.

Authors:  Xiao-Qian Hu; Peng-Chao Guo; Jin-Di Ma; Wei-Fang Li
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-10-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.